Caitrin W McDonough, Ph.D., M.S.

Dr. McDonough received a B.S. in Biochemistry (with a minor in chemistry) from the University of Iowa and then earned a Ph.D in Molecular Medicine and Translational Science from Wake Forest University School of Medicine. After completing graduate studies, she completed a Post-Doctoral Fellowship at the University of Florida in Cardiovascular Pharmacogenomics under the direction of Dr. Julie Johnson, and a M.S. in Biomedical Informatics from the University of Florida.

Currently, Dr. McDonough is an assistant professor in the department of Pharmacotherapy and Translational Research at the University of Florida – College of Pharmacy. She is also an investigator in the Center for Pharmacogenomics and Precision Medicine. Her research focuses on identifying and predicting patients at high risk for cardiovascular disease. Her research group uses multiple methods (regression modeling and machine learning) to integrate data from multiple sources (e.g. electronic health records, insurance claims, ‘omics) to identify factors or signatures that are associated with adverse cardiovascular outcomes and drug response. Current and recently completed funded NIH projects include utilizing data from All of Us to characterize apparent treatment resistant hypertension, adverse cardiovascular outcomes after treatment with a P2Y12 inhibitor, and adverse outcomes with statin therapy. She is also the co-leader of the International Consortium for Antihypertensive Pharmacogenomic Studies, collaborating with groups across the globe to advance antihypertensive pharmacogenomics.